Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Prepaid Assets (2020 - 2025)

Rani Therapeutics Holdings has reported Prepaid Assets over the past 6 years, most recently at $811000.0 for Q3 2025.

  • Quarterly results put Prepaid Assets at $811000.0 for Q3 2025, down 58.77% from a year ago — trailing twelve months through Sep 2025 was $811000.0 (down 58.77% YoY), and the annual figure for FY2023 was $200000.0, down 91.81%.
  • Prepaid Assets for Q3 2025 was $811000.0 at Rani Therapeutics Holdings, down from $857000.0 in the prior quarter.
  • Over the last five years, Prepaid Assets for RANI hit a ceiling of $2.7 million in Q3 2023 and a floor of $165000.0 in Q2 2021.
  • Median Prepaid Assets over the past 5 years was $1.4 million (2022), compared with a mean of $1.5 million.
  • Biggest five-year swings in Prepaid Assets: soared 1182.63% in 2021 and later plummeted 91.81% in 2023.
  • Rani Therapeutics Holdings' Prepaid Assets stood at $2.1 million in 2021, then grew by 14.01% to $2.4 million in 2022, then plummeted by 91.81% to $200000.0 in 2023, then soared by 883.5% to $2.0 million in 2024, then plummeted by 58.77% to $811000.0 in 2025.
  • The last three reported values for Prepaid Assets were $811000.0 (Q3 2025), $857000.0 (Q2 2025), and $1.3 million (Q1 2025) per Business Quant data.